Uric acid and cognition in Parkinson's disease: A follow-up study

Parkinsonism and Related Disorders

Volumn 17, Issue 5, 2011, Pages 333-337

  Annanmaki, Tua ^a   Pohja, Marjatta ^b   Parviainen, Tiina ^c   Hakkinen, Paula ^b   Murros, Kari ^b  

^a Meilahti Hospital   (Finland)

^b JORVI HOSPITAL   (Finland)

^c AALTO UNIVERSITY   (Finland)

Author keywords

Cognition; Longitudinal; Parkinson's disease; Uric acid

Indexed keywords

URIC ACID;

ADULT; AGED; ALERTNESS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; LONGITUDINAL STUDY; MALE; MENTAL DETERIORATION; NEUROPSYCHOLOGICAL TEST; NUTRITIONAL ASSESSMENT; PARKINSON DISEASE; PRIORITY JOURNAL; PROGNOSIS; TASK PERFORMANCE; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL;

AGED; COGNITION DISORDERS; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; URIC ACID;

EID: 79957935958     PISSN: 13538020     EISSN: 18735126     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2011.01.013     Document Type: Article

References (29)

1. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant functions of uric acid. Biochem J 1986 May 1, 235(3):747-754.
2. Jenner P. Oxidative mechanisms in nigral cell death in Parkinson's disease. Mov Disord 1998, 13(Suppl. 1):24-34.
3. de Lau L.M., Koudstaal P.J., Hofman A., Breteler M.M. Serum uric acid levels and the risk of Parkinson disease. Ann Neurol 2005 Nov, 58(5):797-800.
4. Davis J.W., Grandinetti A., Waslien C.I., Ross G.W., White L.R., Morens D.M. Observations on serum uric acid levels and the risk of idiopathic Parkinson's disease. Am J Epidemiol 1996 Sep 1, 144(5):480-484.
5. Schwarzschild M.A., Schwid S.R., Marek K., Watts A., Lang A.E., Oakes D., et al. Serum urate as a predictor of clinical and radiolographic progression in Parkinson disease. Arch Neurol 2008 Jun, 65(6):716-723.
6. Ascherio A., LeWitt P.A., Xu K., Eberly S., Watts A., Matson W.R., et al. Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 2009 Dec, 66(12):1460-1468.
7. Aarsland D., Bronnick K., Larsen J.P., Tysnes O.B., Alves G., For the Norwegian ParkWest Study Group Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest Study. Neurology 2009 Mar, 31(13):1121-1126.
8. Aarsland D., Andersen K., Larsen J.P., Perry R., Wentzel-Larsen T., Lolk A., et al. The rate of cognitive decline in Parkinson disease. Arch Neurol 2004 Dec, 61(12):1906-1911.
9. Azuma T., Cruz R.F., Bayles K.A., Tomoeda C.K., Montgomery E.B. A longitudinal study of neuropsychological change in individuals with Parkinson's disease. Int J Geriatr Psychiatry 2003 Dec, 18(12):1115-1120.
10. Muslimovic D., Post B., Speelman J.D., De Haan R.J., Schmand B. Cognitive decline in Parkinson's disease: a prospective longitudinal study. J Int Neuropsychol Soc 2009 May, 15(3):426-437.
11. Muslimovic D., Schmand B., Speelman J.D., de Haan R.J. Course of cognitive decline in Parkinson's disease: a meta-analysis. J Int Neuropsychol Soc 2007 Nov, 13(6):920-932.
12. Williams-Gray C.H., Foltynie T., Brayne C.E., Robbins T.W., Barker R.A. Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 2007 Jul, 130(Pt 7):1787-1798.
13. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., Mindham R.H., et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 2000 Apr 25, 54(8):1596-1602.
14. Aarsland D., Andersen K., Larsen J.P., Lolk A., Kragh-Sorensen P. Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Arch Neurol 2003 Mar, 60(3):387-392.
15. Annanmaki T., Pessala A., Hokkanen L., Murros K. Uric acid associates with cognition in Parkinson's disease. Parkinsonism Related Disord 2008 Nov, 14(7):576-584.
16. Annanmaki T., Muuronen A., Murros K. Low plasma uric acid level in Parkinson's disease. Mov Disord 2007 Jun, 15(8):1133-1137.
17. Beck A.T., Beck R.W. Screening depressed patients in family practice. A rapid technic. Postgraduate Med 1972, 52:427-442.
18. Folstein M.F., Folstein S.E., McHugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psych Res 1975, 12:189-198.
19. Wechsler D. Manual for the Wechsler adult intelligence scale.1981.
20. Wechsler D. Manual for the Wechsler memory scale. 1987.
21. Wechsler D. Manual for the Wechsler memory scale - third edition. 1997.
22. Lezak. Neuropsychological assessment third edition. 1995, pp. 381-384.
23. Wilson BA, Alderman N, Burgess PW, Emslie H, Evans JJ. Behavioural assessment of the dysexecutive syndrome. 1996.
24. Revonsuo P.P.R. CogniSpeed the computer based measurement of cognitive processing 1995, Aboa Tech Ltd, University of Turku, Finland.
25. Uc E.Y., McDermott M.P., Marder K.S., Anderson S.W., Litvan I., Como P.G., et al. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort. Neurology 2009 Nov 3, 73(18):1469-1477.
26. Mahieux F., Fenelon G., Flahault A., Manifacier M.J., Michelet D., Boller F. Neuropsychological prediction of dementia in Parkinson's disease. J Neurol Neurosurg Psychiatry 1998 Feb, 64(2):178-183.
27. Andreadou E., Nikolaou C., Gournaras F., Rentzos M., Boufidou F., Tsoutsou A., et al. Serum uric acid levels in patients with Parkinson's disease: their relationship to treatment and disease duration. Clin Neurol Neurosurg 2009 Nov, 111(9):724-728.
28. Chen H., Zhang S.M., Hernan M.A., Willett W.C., Ascherio A. Weight loss in Parkinson's disease. Ann Neurol 2003 May, 53(5):676-679.
29. Logroscino G., Sesso H.D., Paffenbarger R.S., Lee I.M. Body mass index and risk of Parkinson's disease: a prospective cohort study. Am J Epidemiol 2007 Nov 15, 166(10):1186-1190.